Skip to content
AnalystLens

Humana Annual Report (Amendment), Year Ended Dec 31, 2002

Filing Date
Filed April 3, 2003
Period End
December 31, 2002
Security
HUM
In the record · 2016–202610-K1110-Q328-K199

HUM filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 199 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Aug ’19Aug ’19
  3. Leadership change8-K · Mar ’22Mar ’22
  4. Leadership change8-K · Dec ’25Dec ’25

01—Abstract

Summary

Summary of the 10-K/A filed April 3, 2003. Cited figures are marked; the original filing is the authoritative source.

Humana Inc. filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2002, to correct an error on the cover page.

The corrected disclosure states that the aggregate market value of voting stock held by non-affiliates was $2,480,270,991a as of June 28, 2002, calculated at an average price of $15.59 per share. The originally reported figure of $480,270,991 was an error. The amendment states that there are no other changes to the Form 10-K for 2002.

The cover page also reports 160,767,347 shares of common stock outstanding as of March 19, 2003. The registrant is a Delaware corporation headquartered at 500 West Main Street, Louisville, Kentucky.

Its securities registered under Section 12(b) are its $0.16b 2/3 par value common stock and its 7 1/4% Senior Notes due August 2006, both listed on the New York Stock Exchange. Parts II and III of the Form 10-K incorporate by reference portions of the Registrant's Proxy Statement for the Annual Meeting of Stockholders scheduled for May 15, 2003.

02—Key points

Key Highlights

  1. Corrected non-affiliate market value of voting stock as of June 28, 2002 to $2,480,270,991, replacing the originally reported $480,270,991
  2. Market value calculated using an average price of $15.59 per share on June 28, 2002
  3. 160,767,347 shares of common stock outstanding as of March 19, 2003
  4. Registered securities include common stock ($0.16 2/3 par value) and 7 1/4% Senior Notes due August 2006, both listed on the New York Stock Exchange
  5. Amendment states there are no other changes to the Form 10-K for the year ended December 31, 2002
  6. Parts II and III incorporate the Proxy Statement for the Annual Meeting of Stockholders scheduled for May 15, 2003
  7. Headquartered at 500 West Main Street, Louisville, Kentucky; incorporated in Delaware

03—Questions

Frequently Asked Questions

  1. Why was this amendment filed?

    The amendment corrects an error on the cover page. The non-affiliate market value of voting stock as of June 28, 2002 was restated from $480,270,991 to $2,480,270,991.

  2. What was the aggregate market value of stock held by non-affiliates?

    As of June 28, 2002, the aggregate market value of voting stock held by non-affiliates was $2,480,270,991, calculated using an average price of $15.59 per share on that date.

  3. How many shares of common stock were outstanding?

    As of March 19, 2003, there were 160,767,347 shares of the Registrant's common stock outstanding.

  4. Where are Humana's registered securities traded?

    The common stock, $0.16 2/3 par value, and the 7 1/4% Senior Notes due August 2006 are registered on the New York Stock Exchange.

  5. Does this amendment change anything else in the 2002 Form 10-K?

    No. The filing states that there are no other changes to the Form 10-K for the year ended December 31, 2002.

04—Continue

← View all 10-K filings